{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:19:18Z","timestamp":1788304758088,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00405-026-10013-5","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T21:01:34Z","timestamp":1768942894000},"page":"3503-3512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic effect of anti-neuroinflammatory supplement combined with olfactory training on post-covid olfactory dysfunction: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"283","author":[{"given":"Ya","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-765X","authenticated-orcid":false,"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiping","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"10","key":"10013_CR1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","volume":"53","author":"SJ Yong","year":"2021","unstructured":"Yong SJ (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 53(10):737\u2013754. https:\/\/doi.org\/10.1080\/23744235.2021.1924397","journal-title":"Infect Dis"},{"issue":"9","key":"10013_CR2","doi-asserted-by":"publisher","first-page":"CD013877","DOI":"10.1002\/14651858.CD013877.pub3","volume":"9","author":"KE Webster","year":"2022","unstructured":"Webster KE, O\u2019Byrne L, MacKeith S, Philpott C, Hopkins C, Burton MJ (2022) Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev 9(9):CD013877. https:\/\/doi.org\/10.1002\/14651858.CD013877.pub3PMID: 36063364; PMCID: PMC9443936","journal-title":"Cochrane Database Syst Rev"},{"key":"10013_CR3","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re\u2019em Y, Redfield S, Austin JP, Akrami A (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101019Epub 2021 Jul 15. PMID: 34308300; PMCID: PMC8280690","journal-title":"EClinicalMedicine"},{"key":"10013_CR4","doi-asserted-by":"publisher","unstructured":"Tan BKJ, Han R, Zhao JJ, Tan NKW, Quah ESH, Tan CJ, Chan YH, Teo NWY, Charn TC, See A, Xu S, Chapurin N, Chandra RK, Chowdhury N, Butowt R, von Bartheld CS, Kumar BN, Hopkins C, Toh ST (2022) Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. ;378:e069503. https:\/\/doi.org\/10.1136\/bmj-2021-069503. Erratum in: BMJ. 2022;378:o1939. doi: 10.1136\/bmj.o1939. PMID: 35896188; PMCID: PMC9326326","DOI":"10.1136\/bmj-2021-069503"},{"issue":"1","key":"10013_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tins.2022.11.003","volume":"46","author":"R Butowt","year":"2023","unstructured":"Butowt R, Bilinska K, von Bartheld CS (2023) Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci 46(1):75\u201390. https:\/\/doi.org\/10.1016\/j.tins.2022.11.003","journal-title":"Trends Neurosci"},{"issue":"1","key":"10013_CR6","doi-asserted-by":"publisher","first-page":"e054598","DOI":"10.1136\/bmjopen-2021-054598","volume":"12","author":"HQM Tan","year":"2022","unstructured":"Tan HQM, Pendolino AL, Andrews PJ, Choi D (2022) Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study. BMJ Open 12(1):e054598. https:\/\/doi.org\/10.1136\/bmjopen-2021-054598PMID: 35078845; PMCID: PMC8795927","journal-title":"BMJ Open"},{"issue":"3","key":"10013_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/lary.20101","volume":"119","author":"T Hummel","year":"2009","unstructured":"Hummel T, Rissom K, Reden J, H\u00e4hner A, Weidenbecher M, H\u00fcttenbrink KB (2009) Effects of olfactory training in patients with olfactory loss. Laryngoscope 119(3):496\u20139. https:\/\/doi.org\/10.1002\/lary.20101","journal-title":"Laryngoscope"},{"issue":"4","key":"10013_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/19458924221150977","volume":"37","author":"SH Hwang","year":"2023","unstructured":"Hwang SH, Kim SW, Basurrah MA, Kim DH (2023) The efficacy of olfactory training as a treatment for olfactory disorders caused by Coronavirus disease-2019: a systematic review and meta-analysis. Am J Rhinol Allergy 37(4):495\u2013501. https:\/\/doi.org\/10.1177\/19458924221150977","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"10013_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40521-021-00297-9","volume":"9","author":"TJ Wu","year":"2022","unstructured":"Wu TJ, Yu AC, Lee JT (2022) Management of post-COVID-19 olfactory dysfunction. Curr Treat Options Allergy 9(1):1\u201318. https:\/\/doi.org\/10.1007\/s40521-021-00297-9","journal-title":"Curr Treat Options Allergy"},{"issue":"2","key":"10013_CR10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s12035-015-9253-8","volume":"52","author":"SD Skaper","year":"2015","unstructured":"Skaper SD, Facci L, Barbierato M, Zusso M, Bruschetta G, Impellizzeri D, Cuzzocrea S, Giusti P (2015) N-palmitoylethanolamine and neuroinflammation: a novel therapeutic strategy of resolution. Mol Neurobiol 52(2):1034\u201342. https:\/\/doi.org\/10.1007\/s12035-015-9253-8","journal-title":"Mol Neurobiol"},{"issue":"8","key":"10013_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/biom12081161","volume":"12","author":"M Assogna","year":"2022","unstructured":"Assogna M, Di Lorenzo F, Martorana A, Koch G (2022) Synaptic effects of palmitoylethanolamide in neurodegenerative disorders. Biomolecules 12(8):1161. https:\/\/doi.org\/10.3390\/biom12081161PMID: 36009055; PMCID: PMC9405819","journal-title":"Biomolecules"},{"issue":"17","key":"10013_CR12","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.3390\/nu15173701","volume":"15","author":"M Pirro","year":"2023","unstructured":"Pirro M, Ferri L, Piccioni L, Bellucci AM, Bartolucci F, Russo A, Piga A, Ciaramaglia PL, Lucangeli M, Russo AM, Cuzzocrea S, Evangelista M (2023) What is the role of palmitoylethanolamide Co-Ultramicronized with Luteolin on the symptomatology reported by patients suffering from long COVID? A retrospective analysis performed by a group of general practitioners in a Real-Life setting. Nutrients 15(17):3701. https:\/\/doi.org\/10.3390\/nu15173701PMID: 37686733; PMCID: PMC10490268","journal-title":"Nutrients"},{"issue":"6","key":"10013_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/emermed-2020-209567","volume":"37","author":"M Amir-Behghadami","year":"2020","unstructured":"Amir-Behghadami M, Janati A (2020) Population, intervention, comparison, outcomes and study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J 37(6):387. https:\/\/doi.org\/10.1136\/emermed-2020-209567","journal-title":"Emerg Med J"},{"key":"10013_CR14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group; Cochrane Statistical Methods Group (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928PMID: 22008217; PMCID: PMC3196245","journal-title":"BMJ"},{"issue":"10","key":"10013_CR15","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.2174\/1570159X20666220420113513","volume":"20","author":"A Di Stadio","year":"2022","unstructured":"Di Stadio A, D\u2019Ascanio L, Vaira LA, Cantone E, De Luca P, Cingolani C, Motta G, De Riu G, Vitelli F, Spriano G, De Vincentiis M, Camaioni A, La Mantia I, Ferreli F, Brenner MJ (2022) Ultramicronized Palmitoylethanolamide and Luteolin supplement combined with olfactory training to treat post-COVID-19 olfactory impairment: a multi-center double-blinded randomized placebo- controlled clinical trial. Curr Neuropharmacol 20(10):2001\u20132012. https:\/\/doi.org\/10.2174\/1570159X20666220420113513","journal-title":"Curr Neuropharmacol"},{"key":"10013_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000539651","volume":"86","author":"J Gellrich","year":"2024","unstructured":"Gellrich J, Czaplewski L, H\u00e4hner A, Hummel T (2024) Palmitoylethanolamide and Luteolin for postinfectious olfactory disorders: how clinically meaningful is its effect? ORL J Otorhinolaryngol Relat Spec 86:118\u2013123. https:\/\/doi.org\/10.1159\/000539651","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"16","key":"10013_CR17","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.3390\/cells11162552","volume":"11","author":"P De Luca","year":"2022","unstructured":"De Luca P, Camaioni A, Marra P, Salzano G, Carriere G, Ricciardi L, Pucci R, Montemurro N, Brenner MJ, Di Stadio A (2022) Effect of Ultra-Micronized palmitoylethanolamide and Luteolin on olfaction and memory in patients with long COVID: results of a longitudinal study. Cells 11(16):2552. https:\/\/doi.org\/10.3390\/cells11162552PMID: 36010630; PMCID: PMC9406356","journal-title":"Cells"},{"key":"10013_CR18","doi-asserted-by":"publisher","unstructured":"Di Stadio A, Bernitsas E, La Mantia I, Brenner MJ, Ralli M, Vaira LA, Colizza A, Cavaliere C, Laudani M, Frohman TC, De Vincentiis M, Frohman EM, Altieri M (2023) Targeting neuroinflammation to alleviate chronic olfactory dysfunction in long COVID: A role for investigating Disease-Modifying therapy (DMT)? Life (Basel). 13(1):226. https:\/\/doi.org\/10.3390\/life13010226. PMID: 36676175; PMCID: PMC9863729","DOI":"10.3390\/life13010226"},{"issue":"11","key":"10013_CR19","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.26355\/eurrev_202106_26059","volume":"25","author":"L D'Ascanio","year":"2021","unstructured":"D\u2019Ascanio L, Vitelli F, Cingolani C, Maranzano M, Brenner MJ, Di Stadio A (2021) Randomized clinical trial \u201colfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin\u201d: preliminary results. Eur Rev Med Pharmacol Sci 25(11):4156\u20134162. https:\/\/doi.org\/10.26355\/eurrev_202106_26059","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"10013_CR20","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1007\/s00405-023-08085-8","volume":"280","author":"Arianna Di Stadio","year":"2023","unstructured":"Di Stadio Arianna et al (2023) Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial. Eur Arch Otorhinolaryngol 280(11):4949\u20134961","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"10013_CR21","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s00405-024-08548-6","volume":"281","author":"E Cantone","year":"2024","unstructured":"Cantone E, D\u2019Ascanio L, De Luca P, Roccamatisi D, La La Mantia I, Brenner MJ, Di Stadio A (2024) Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics. Eur Arch Otorhinolaryngol 281(7):3671\u20133678. https:\/\/doi.org\/10.1007\/s00405-024-08548-6","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"10013_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s41061-021-00353-7","volume":"379","author":"I Ahmad","year":"2021","unstructured":"Ahmad I, Pawara R, Surana S, Patel H (2021) The repurposed ACE2 inhibitors: SARS-CoV-2 entry blockers of COVID-19. Top Curr Chem 379(6):40. https:\/\/doi.org\/10.1007\/s41061-021-00353-7","journal-title":"Top Curr Chem"},{"issue":"5","key":"10013_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak W, Huang N, B\u00e9cavin C et al (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26(5):681\u2013687","journal-title":"Nat Med"},{"issue":"676","key":"10013_CR24","doi-asserted-by":"publisher","first-page":"eadd0484","DOI":"10.1126\/scitranslmed.add0484","volume":"14","author":"JB Finlay","year":"2022","unstructured":"Finlay JB, Brann DH, Abi Hachem R, Jang DW, Oliva AD, Ko T, Gupta R, Wellford SA, Moseman EA, Jang SS, Yan CH, Matsunami H, Tsukahara T, Datta SR, Goldstein BJ (2022) Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci Transl Med 14(676):eadd0484. https:\/\/doi.org\/10.1126\/scitranslmed.add0484Epub 2022 Dec 21. PMID: 36542694; PMCID: PMC10317309","journal-title":"Sci Transl Med"},{"issue":"3","key":"10013_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00005537-199903000-00008","volume":"109","author":"KJ Fong","year":"1999","unstructured":"Fong KJ, Kern RC, Foster JD et al (1999) Olfactory secretion and sodium, potassium-adenosine triphosphatase: regulation by corticosteroids. Laryngoscope 109(3):383\u2013388","journal-title":"Laryngoscope"},{"issue":"1","key":"10013_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4193\/Rhin22.221","volume":"61","author":"V Asvapoositkul","year":"2023","unstructured":"Asvapoositkul V, Samuthpongtorn J, Aeumjaturapat S, Snidvongs K, Chusakul S, Seresirikachorn K, Kanjanaumporn J (2023) Therapeutic options of post-COVID-19 related olfactory dysfunction: a systematic review and meta-analysis. Rhinology 61(1):2\u201311. https:\/\/doi.org\/10.4193\/Rhin22.221","journal-title":"Rhinology"},{"key":"10013_CR27","doi-asserted-by":"publisher","first-page":"16676","DOI":"10.1038\/srep16676","volume":"5","author":"M Barbierato","year":"2015","unstructured":"Barbierato M, Facci L, Marinelli C, Zusso M, Argentini C, Skaper SD, Giusti P (2015) Co-ultramicronized Palmitoylethanolamide\/Luteolin promotes the maturation of oligodendrocyte precursor cells. Sci Rep 5:16676. https:\/\/doi.org\/10.1038\/srep16676PMID: 26578323; PMCID: PMC4649338","journal-title":"Sci Rep"},{"issue":"8","key":"10013_CR28","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/biomedicines11082189","volume":"11","author":"AP Capra","year":"2023","unstructured":"Capra AP, Ardizzone A, Crupi L, Calapai F, Campolo M, Cuzzocrea S, Esposito E (2023) Efficacy of palmitoylethanolamide and Luteolin association on Post-Covid olfactory dysfunction: A systematic review and Meta-Analysis of clinical studies. Biomedicines 11(8):2189. https:\/\/doi.org\/10.3390\/biomedicines11082189PMID: 37626685; PMCID: PMC10452638","journal-title":"Biomedicines"},{"issue":"1","key":"10013_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12975-015-0440-8","volume":"7","author":"C Caltagirone","year":"2016","unstructured":"Caltagirone C, Cisari C, Schievano C, Di Paola R, Cordaro M, Bruschetta G, Esposito E, Cuzzocrea S (2016) Co-ultramicronized Palmitoylethanolamide\/Luteolin in the treatment of cerebral ischemia: from rodent to man. Transl Stroke Res 7(1):54\u201369. https:\/\/doi.org\/10.1007\/s12975-015-0440-8","journal-title":"Transl Stroke Res"},{"key":"10013_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clinph.2022.10.017","volume":"145","author":"V Versace","year":"2023","unstructured":"Versace V, Ortelli P, Dezi S, Ferrazzoli D, Alibardi A, Bonini I, Engl M, Maestri R, Assogna M, Ajello V, Pucks-Faes E, Saltuari L, Sebastianelli L, Kofler M, Koch G (2023) Co-ultramicronized palmitoylethanolamide\/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome. Clin Neurophysiol 145:81\u201388. https:\/\/doi.org\/10.1016\/j.clinph.2022.10.017","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10013_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOO.0000000000000783","volume":"30","author":"K Karamali","year":"2022","unstructured":"Karamali K, Elliott M, Hopkins C (2022) COVID-19 related olfactory dysfunction. Curr Opin Otolaryngol Head Neck Surg 30(1):19\u201325. https:\/\/doi.org\/10.1097\/MOO.0000000000000783","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"16","key":"10013_CR32","doi-asserted-by":"publisher","first-page":"8717","DOI":"10.3390\/ijms22168717","volume":"22","author":"M Campolo","year":"2021","unstructured":"Campolo M, Crupi R, Cordaro M, Cardali SM, Ardizzone A, Casili G, Scuderi SA, Siracusa R, Esposito E, Conti A, Cuzzocrea S (2021) Co-Ultra pealut enhances endogenous repair response following moderate traumatic brain injury. Int J Mol Sci 22(16):8717. https:\/\/doi.org\/10.3390\/ijms22168717PMID: 34445417; PMCID: PMC8395716","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10013_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00405-022-07570-w","volume":"280","author":"A Yaylac\u0131","year":"2023","unstructured":"Yaylac\u0131 A, Azak E, \u00d6nal A, Akt\u00fcrk DR, Karadenizli A (2023) Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell. Eur Arch Otorhinolaryngol 280(2):757\u2013763. https:\/\/doi.org\/10.1007\/s00405-022-07570-w","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10013_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MOO.0000000000000328","volume":"25","author":"ZM Patel","year":"2017","unstructured":"Patel ZM (2017) The evidence for olfactory training in treating patients with olfactory loss. Curr Opin Otolaryngol Head Neck Surg 25(1):43\u201346","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"1","key":"10013_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4193\/Rhino16.195","volume":"55","author":"A Sorokowska","year":"2017","unstructured":"Sorokowska A, Drechsler E, Karwowski M et al (2017) Effects of olfactory training: a meta-analysis. Rhinology 55(1):17\u201326","journal-title":"Rhinology"},{"issue":"4","key":"10013_CR36","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/lary.24340","volume":"124","author":"M Damm","year":"2014","unstructured":"Damm M, Pikart LK, Reimann H et al (2014) Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope 124(4):826\u2013831","journal-title":"Laryngoscope"},{"issue":"2","key":"10013_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0194599820943550","volume":"164","author":"N Kattar","year":"2021","unstructured":"Kattar N, Do TM, Unis GD, Migneron MR, Thomas AJ, McCoul ED (2021) Olfactory training for postviral olfactory dysfunction: systematic review and meta-analysis. Otolaryngol Head Neck Surg 164(2):244\u2013254. https:\/\/doi.org\/10.1177\/0194599820943550","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10013-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10013-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10013-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:04:14Z","timestamp":1781053454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10013-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10013"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10013-5","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors have no competing interests to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}